FdaApplication

ANDA 091517

Back to search

Identifiers

Properties

PropertyValue
applicant_nameKENTON CHEMICALS AND PHARMACEUTICALS CORP
application_typeANDA
approval_date2015-04-24

Products (3)

ProductActive ingredientStrengthDosage form
REPAGLINIDEREPAGLINIDE0.5MGTABLET;ORAL
REPAGLINIDEREPAGLINIDE1MGTABLET;ORAL
REPAGLINIDEREPAGLINIDE2MGTABLET;ORAL

3 products